Clinical trial
Effect of Combination of Intravenous Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Patients With Heart Failure and Iron Deficiency.
NCT06434025 is registered in ClinicalTrials.gov with Hospital de Clinicas de Porto Alegre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Combination of Intravenous Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Patients With Heart Failure and Iron Deficiency.
- Lead sponsor
- Hospital de Clinicas de Porto Alegre
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- May 24, 2024
- Completion date
- November 24, 2026
- Enrollment
- 99 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.